Bio-Path Holdings (NASDAQ: BPTH) reported Q3 EPS of ($0.32), $0.02 better than the analyst estimate of ($0.34). Revenue for the quarter came in at $0 versus the consensus estimate of $0 .

For earnings history and earnings-related data on Bio-Path Holdings (BPTH) click here.